YAKHAK HOEJI (약학회지)

The Pharmaceutical Society of Korea (대한약학회)
권호 표지

Preparation and Evaluation of Solid lipid Microspheres Containing Cyclosporine A

사이클로스포린을 함유한 고형 지질미립구의 제조와 평가

  • Published : 1995.10.01
Download PDF
⟨ Previous Next ⟩

Abstract

Solid lipid microspheres (SLMs) were prepared using various lipids and solidifying agents, in order to enhance the gastrointestinal absorption of Cyclosporine A (Cs A) which is a practically water-insoluble drug with low systemic bioavailability. Egg lecithin and HCO-60 (polyoxyethylated 60 mol, hydrogenated castor oil) were used as lipids. Stearic acid and stearyl alcohol were used as solidifying agents. Emulsion concentrates containing Cs A were prepared by mixing the melted lipid and solidifying agent with water, employing bile salts as a cosurfactant. SLMs were obtained by dispersing the warm emulsion concentrate in cold distilled water under mechanical stirring, followed by freeze drying. Physical characteristics of each SLM were investigated by particle size analysis, optical microscopy and scanning electron microscopy. Mean particle size of SLMs was in the range of 30 to 40.mu.m. The SLMs were in good appearance with spherical shape before freeze drying, but were deformed partially after freeze drying. Drug loading efficiencies of SLMs were observed as high as 80 to 90% in average. The systemic bioavailability of Cs A from different SLM formula was investigated in rats following oral administration. Cs A in whole blood was extracted and assayed by HPLC. SLMs revealed the higher bioavailabilities than the standard formula based on the marketed product. SLMs might have several advantages over standard formula for enhanced gastrointestinal absorption, controlled release properties, high loading capacity of the water-insoluble drug, and feasibility of solid dosage forms with better stability in storage.

Keywords

References

  1. Clin. Biochem. v.24 Pharmacology and pharmacokinetics of cyclosporine Freeman,D.J.
  2. Transpl. Proceed. v.22 Structure of cyslosporine and its metabolites Wenger,R.M.
  3. Transpl. Proceed. v.22 Pharmacokinetics of cyslosporine. Inter- and intra-individual variations and metabolic pathways Lemaire,M.;Fahr,A.;Maurer,G.
  4. Transpl. Proceed. v.48 Enhancenment of immunosuppression by substitution of fish oil for olive oil as a vehicle or Cyclosporine A Kelley,V.E.;Kirkman,R.L.;Bastos,M.;Barrett,L.V.;Strom,T.B.
  5. Br. J. Clin. Pharmacol. v.34 Enhancement of the oral absorption of cyclosporine in man Drewe,J.;Meier,F.;Vonderscher,J.;Kiss,D.;Posanski,L.
  6. Int. J. Pharm. v.44 Increased systemic availability of cyclosporine A by formaulation design. pharmacokinetic consideration on its transport Takada,K.;Furuya,Y.;Yoshikawa,H.;Murashini,S.;Yasumura,T.;Oka,T.
  7. J. Pharmacobio-Dyn. v.11 Biological and pharmaceutical factors affecting the absorption and lymphatic delivery of cyclosporine A from gastrointestinal tract Takada,K.;Furuya,Y.;Yoshikawa,H.;Murashini,S.
  8. Chem. Pharm. Bull. v.37 Enteric solid dispersion cyclosporine A having potential to deliver Cs A into lymphatics Takada,K.;Oh-Hashi,M.;Furuya,Y.;Yoshikawa,H.;Murashini,S.
  9. Dispersed system, Pharmaceutical Dosage Forms v.2 Injectable emulsions and suspensions Boyteet,J.B.;Davis,C.W.
  10. J. Pharm. Pharmacol. v.35 Anti-inflammatory effect of in domethacin ester incorporated in a lipid microsphere Mizushima,Y.;Wada,Y.;Etoh,Y.;Watanabe,K.
  11. J. Control. Rel. v.28 Recent clinical studies on lipo-PEG₁and lipo-PEG₂: lipo-PEG₁and lipo-PEG₂incorporated in lipid microspheres, for tergeted delivery Mizushima,Y.;Toyata,T.;Okita,K.;Ohtomo,E.
  12. J. Pharm. Pharmacol. v.35 Prostaglandin E₁is more effective, when in corporated in lipid microspheres, for treatment of peripheral vascular diseases in man Mizushima,Y.;Yanagawa,A.;Hoshi,K.
  13. J. Pharm. Pharmacol. v.34 Use of a lipid emulsion as a novel carrier for corticosteroids Mizushima,Y.;Hamano,T.;Yokoyama,K.
  14. Int. J. Pharm. v.105 Incorporation in lipospheres of [D-Trp-6]LHRH Morel,S.;Gasco,M.R.;Cavalli,R.
  15. J. Pharm. Sci. v.80 Polysaccharide-coated oil droplets in oil-water emulsions as targetable carriers for lipophilis drugs Yamamoto,K.;Kato,T.;Kawahara,M.;Koyama,N.;Watanabe,S.;Miyake,Y.;Sunamoto,J.
  16. Int. J. Pharm. v.109 The solubilization of lipophilic derivatives of podophyllotoxins in sub-micronsized lipid emulsions and their cytotoxic activity against cancer cells in culture Lundberg,B.
  17. Int. J. Pharm. v.107 The structure elucidation of semisolid w/o emulsion systems containing silicone surfactant Ga$\u{s}$perlin,M.;Kristl,J.;mid-Korbar,J.;Ker,J.
  18. Int. J. Pharm. v.89 Solid lipospheres of doxorubicin and idarubicin Cavalli,R.;Caputo,O.;Gasco,M.R.
  19. Res. Commun. Chem. Pathol. Pharmacol. v.48 High performance chromatographic determination of cyclosporine A in body fluids Takada,K.;Shibata,N.;Yoshimura,H.;Yoshikawa,H.;Muranishi,S.
  20. Pharm. Res. v.6 Synthesis of gelatin microsphere containing interferon Tobata,Y.;Ikada,Y.
  21. Int. J. Pharm. v.822 Therapeutic possibilities of drugs encapsulated in erythrocytes Lewis,D.A.;Alpar,H.O.
  22. Chem. Pharm. Bull v.34 Preparation and evaluation in vitro and in vivo of fibrinogen microsphere containing adriamycin Miyazaki,S.;Hashiguchi,N.;Hou,W.;Yokochi,C.;Takada,M.
  23. J. Microencapsulation v.6 Albumin microsphere Ⅰ. physical characteristics Gupta,P.K.;Hung,C.T.